 |
|
Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study
Sinyoung Song, Yeon Hoon Lee, Joon Pio Hong, Tae Suk Oh
Arch Craniofac Surg. 2018;19(3):168-174. Published online 2018 Sep 20 DOI: https://doi.org/10.7181/acfs.2018.01886
|
|
Citations to this article as recorded by
 Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
Yan Wu, Fang Fang, Wei Lai, Chengxin Li, Li Li, Quanzhong Liu, Jianyun Lu, Xiaowen Pang, Jiaming Sun, Xiaofeng Shi, Philippe Picaut, Inna Prygova, Bill Andriopoulos, Qiuning Sun
Aesthetic Plastic Surgery.2023; 47(1): 351. CrossRef Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study
Bok Ki Jung, Hojin Park, Young Woo Cheon, In Sik Yun, Jong-Woo Choi, Han Jo Kim, Mu Young Lee, Byeong Su Kang, Tae Jo Kang
Journal of Cranio-Maxillofacial Surgery.2023; 51(5): 332. CrossRef Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Soo-Kyung Lee, Myoung Shin Kim, Soon-Hyo Kwon, Bo Young Chung, Se Hee Han, Hyoung Jun Kim
Journal of Clinical Medicine.2023; 12(19): 6326. CrossRef Facial rejuvenation treatments: a clinical review of botulinum toxin A, microneedling, hyaluronic acid dermal filler and intense pulsed light
Emma Coleman
Journal of Aesthetic Nursing.2022; 11(2): 50. CrossRef Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
Supriyo Choudhury, Mark R. Baker, Suparna Chatterjee, Hrishikesh Kumar
Toxins.2021; 13(1): 58. CrossRef Efficacy and Safety of a New Botulinum Toxin (HU-014) Versus Existing Onabotulinumtoxin A in Subjects With Moderate to Severe Glabellar Lines
Kwang Ho Yoo, Yang Won Lee, Ji Su Lee, Soon Hyo Kwon, Chang Hun Huh, Beom Joon Kim
Dermatologic Surgery.2021; 47(3): e91. CrossRef Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
Richard Glogau, Theda C. Kontis, Yan Liu, Conor J. Gallagher
Dermatologic Surgery.2021; 47(12): 1579. CrossRef Neurotoxin Impurities: A Review of Threats to Efficacy
Je-Young Park, Owen Sunga, Rungsima Wanitphakdeedecha, Jürgen Frevert
Plastic and Reconstructive Surgery - Global Open.2020; 8(1): e2627. CrossRef
|